Literature DB >> 16557267

Strategies for therapeutic targeting of the p53 pathway in cancer.

K G Wiman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16557267     DOI： 10.1038/sj.cdd.4401921

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  36 in total

1.  Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.

Authors:  Drew D Dudgeon; Sunita N Shinde; Tong Ying Shun; John S Lazo; Christopher J Strock; Kenneth A Giuliano; D Lansing Taylor; Patricia A Johnston; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-08       Impact factor: 1.738

2.  Casein kinase 2 inhibition differentially modulates apoptotic effect of trichostatin A against epithelial ovarian carcinoma cell lines.

Authors:  Chung Soo Lee; Eun-Ra Jang; Yun Jeong Kim; Soon Chul Myung; Wonyong Kim
Journal:  Mol Cell Biochem       Date:  2009-12-18       Impact factor: 3.396

3.  Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

Authors:  G Renner; H Janouskova; F Noulet; V Koenig; E Guerin; S Bär; J Nuesch; F Rechenmacher; S Neubauer; H Kessler; A-F Blandin; L Choulier; N Etienne-Selloum; M Lehmann; I Lelong-Rebel; S Martin; M Dontenwill
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

4.  Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway.

Authors:  Chung Soo Lee; Eun-Ra Jang; Yun Jeong Kim; Soon Chul Myung; Wonyong Kim; Min Won Lee
Journal:  Invest New Drugs       Date:  2010-12-01       Impact factor: 3.850

5.  Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination.

Authors:  Purvi Bhatt; Claire d'Avout; Naomi S Kane; James A Borowiec; Anjana Saxena
Journal:  FEBS J       Date:  2011-12-19       Impact factor: 5.542

6.  Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins.

Authors:  Yun Jeong Kim; Seon Ae Lee; Soon Chul Myung; Wonyong Kim; Chung Soo Lee
Journal:  Mol Cell Biochem       Date:  2011-07-29       Impact factor: 3.396

7.  QM-MM simulations on p53-DNA complex: a study of hot spot and rescue mutants.

Authors:  Shruti Koulgi; Archana Achalere; Neeru Sharma; Uddhavesh Sonavane; Rajendra Joshi
Journal:  J Mol Model       Date:  2013-11-21       Impact factor: 1.810

Review 8.  Targeting the MDM2-p53 interaction for cancer therapy.

Authors:  Sanjeev Shangary; Shaomeng Wang
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

9.  A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.

Authors:  Surojit Sur; Raymond Pagliarini; Fred Bunz; Carlo Rago; Luis A Diaz; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

10.  DNA vaccination with a mutated p53 allele induces specific cytolytic T cells and protects against tumor cell growth and the formation of metastasis.

Authors:  Matjaz Humar; Martina Maurer; Marc Azemar; Bernd Groner
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-10       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.